脊髄小脳変性症(Spinocerebellar Ataxias):世界の治験レビュー(2015年上半期版)

【英語タイトル】Spinocerebellar Ataxias Global Clinical Trials Review, H1, 2015

GlobalDataが出版した調査資料(GDHC2555CTIDB)・商品コード:GDHC2555CTIDB
・発行会社(調査会社):GlobalData
・発行日:2015年1月31日
・ページ数:60
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界における脊髄小脳変性症(Spinocerebellar Ataxias) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 脊髄小脳変性症(Spinocerebellar Ataxias)
  - 当レポートの概要
・脊髄小脳変性症(Spinocerebellar Ataxias):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Spinocerebellar Ataxias Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Spinocerebellar Ataxias Global Clinical Trials Review, H1, 2015″ provides data on the Spinocerebellar Ataxias clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spinocerebellar Ataxias. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spinocerebellar Ataxias. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Spinocerebellar Ataxias 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Spinocerebellar Ataxias to Genetic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Spinocerebellar Ataxias to Genetic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Spinocerebellar Ataxias 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Spinocerebellar Ataxias Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Kissei Pharmaceutical Co., Ltd. 31
Clinical Trial Overview of Kissei Pharmaceutical Co., Ltd. 31
Bioblast Pharma Ltd. 32
Clinical Trial Overview of Bioblast Pharma Ltd. 32
Daiichi Sankyo Company, Limited 33
Clinical Trial Overview of Daiichi Sankyo Company, Limited 33
Clinical Trial Overview of Top Institutes / Government 34
University of South Florida 34
Clinical Trial Overview of University of South Florida 34
National Institute of Neurological Disorders and Stroke 35
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 35
Hospital de Clinicas de Porto Alegre 36
Clinical Trial Overview of Hospital de Clinicas de Porto Alegre 36
University of Florida 37
Clinical Trial Overview of University of Florida 37
Yokohama City University 38
Clinical Trial Overview of Yokohama City University 38
Ministry of Health, Labour and Welfare, Japan 39
Clinical Trial Overview of Ministry of Health, Labour and Welfare, Japan 39
Federico II University 40
Clinical Trial Overview of Federico II University 40
Zhengzhou University 41
Clinical Trial Overview of Zhengzhou University 41
National Yang Ming University 42
Clinical Trial Overview of National Yang Ming University 42
University of Chicago 43
Clinical Trial Overview of University of Chicago 43
Five Key Clinical Profiles 44
Appendix 58
Abbreviations 58
Definitions 58
Research Methodology 59
Secondary Research 59
About GlobalData 60
Contact Us 60
Disclaimer 60
Source 60

List of Tables
Spinocerebellar Ataxias Therapeutics, Global, Clinical Trials by Region, 2015* 7
Spinocerebellar Ataxias Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Spinocerebellar Ataxias Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Spinocerebellar Ataxias Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Spinocerebellar Ataxias Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11
Spinocerebellar Ataxias Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Spinocerebellar Ataxias Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Spinocerebellar Ataxias Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Spinocerebellar Ataxias to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 15
Spinocerebellar Ataxias Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Spinocerebellar Ataxias Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Spinocerebellar Ataxias to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 18
Spinocerebellar Ataxias Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Spinocerebellar Ataxias Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Spinocerebellar Ataxias Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Spinocerebellar Ataxias Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Spinocerebellar Ataxias Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Spinocerebellar Ataxias Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Spinocerebellar Ataxias Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Spinocerebellar Ataxias Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Spinocerebellar Ataxias Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Spinocerebellar Ataxias Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Spinocerebellar Ataxias Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Spinocerebellar Ataxias Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Spinocerebellar Ataxias Therapeutics Clinical Trials Market, Global, Clinical Trials by Kissei Pharmaceutical Co., Ltd., 2015* 31
Spinocerebellar Ataxias Therapeutics Clinical Trials Market, Global, Clinical Trials by Bioblast Pharma Ltd., 2015* 32
Spinocerebellar Ataxias Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 33
Spinocerebellar Ataxias Therapeutics Clinical Trials Market, Global, Clinical Trials by University of South Florida, 2015* 34
Spinocerebellar Ataxias Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2015* 35
Spinocerebellar Ataxias Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital de Clinicas de Porto Alegre, 2015* 36
Spinocerebellar Ataxias Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2015* 37
Spinocerebellar Ataxias Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2015* 38
Spinocerebellar Ataxias Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Health, Labour and Welfare, Japan, 2015* 39
Spinocerebellar Ataxias Therapeutics Clinical Trials Market, Global, Clinical Trials by Federico II University, 2015* 40
Spinocerebellar Ataxias Therapeutics Clinical Trials Market, Global, Clinical Trials by Zhengzhou University, 2015* 41
Spinocerebellar Ataxias Therapeutics Clinical Trials Market, Global, Clinical Trials by National Yang Ming University, 2015* 42
Spinocerebellar Ataxias Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2015* 43

List of Figures
Spinocerebellar Ataxias Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Spinocerebellar Ataxias Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Spinocerebellar Ataxias Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Spinocerebellar Ataxias Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Proportion of Spinocerebellar Ataxias to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 15
Spinocerebellar Ataxias Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Spinocerebellar Ataxias Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Spinocerebellar Ataxias to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 18
Spinocerebellar Ataxias Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Spinocerebellar Ataxias Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Spinocerebellar Ataxias Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Spinocerebellar Ataxias Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Spinocerebellar Ataxias Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Spinocerebellar Ataxias Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Spinocerebellar Ataxias Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Spinocerebellar Ataxias Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Spinocerebellar Ataxias Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Spinocerebellar Ataxias Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Spinocerebellar Ataxias Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 59

【レポートのキーワード】

脊髄小脳変性症(Spinocerebellar Ataxias)、治験、臨床試験、治験、治療薬

★調査レポート[脊髄小脳変性症(Spinocerebellar Ataxias):世界の治験レビュー(2015年上半期版)] (コード:GDHC2555CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[脊髄小脳変性症(Spinocerebellar Ataxias):世界の治験レビュー(2015年上半期版)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆